Overview

Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients

Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of desmopressin on symptoms of nocturia in patients with Obstructive Sleep Apnoea (OSA). The improvement of sleep quality and the quality of life will be measured.
Phase:
Phase 3
Details
Lead Sponsor:
Chinese University of Hong Kong
Treatments:
Deamino Arginine Vasopressin